Search results for:
hyaluronidase-trastuzumab
hyaluronidase-trastuzumab
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| Hyaluronidase-Trastuzumab-oysk |
SOLUTION, SUBCUTANEOUS |
2000 units-120 mg/mL (10,000 units-600 mg/5 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Jul. 19, 2023
UNC Health
System Formulary Restriction:
Use of Herceptin Hylecta injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use
Herceptin Hylecta orders must be signed by a Hematology/Oncology Attending Physician
A benefits investigation must be completed prior to use
Med Center
UNC Medical Center Formulary Restrictions